Target intelligence / Profile preview

TNFRSF10A divergent transcript (TNFRSF10A-DT)

Target
TNFRSF10A-DT
Molecular classification
Long noncoding RNA (lncRNA), Other (noncoding transcript, not a receptor or enzyme)
01

Overview

TNFRSF10A divergent transcript (TNFRSF10A-DT, LOC389641, PLACT1) is a cytoplasm-localized long noncoding RNA located head-to-head with TNFRSF10A (Death receptor 4) on the human genome[1]. Although little is known about its precise mechanisms, overexpression of TNFRSF10A-DT increases cell death under stress and can regulate necroptotic and inflammatory signaling pathways independently of TNFRSF10A expression[1]. Its dysregulation is implicated in the progression of several cancers (including pancreatic cancer), age-related macular degeneration, and alterations in necroptosis and inflammation. The transcript is not known to be a receptor, enzyme, transporter, or traditional drug target, but likely acts through post-transcriptional and/or protein-interacting roles in the cytoplasm[1]. Please note: TNFRSF10A-DT should not be confused with the protein-coding TNFRSF10A (Death receptor 4, DR4, TRAIL-R1), which is a known therapeutic protein target[1]. Key information is based on referenced genomic investigation and functional studies[1][2]. No drugs currently act on this lncRNA transcript, and its use as a biomarker or therapeutic target remains largely research-based.

Other names
LOC389641PLACT1pancreatic cancer associated transcript 1
02

Biological functions

Regulation of necroptosisRegulation of inflammationMay play a role in cell death and survival signaling
03

Disease associations

Cancer (implicated in tumor progression of pancreatic, lung, and colon cancers)Age-related macular degeneration (implicated via genetic variant rs13278062 within the transcript)Inflammation (potential role via regulation of inflammatory signaling)
04

Biomarkers

rs13278062 SNP (age-related macular degeneration risk)Upregulation or downregulation of TNFRSF10A-DT itself may signal certain cancer or inflammatory phenotypes

Beyond the preview

Go deeper on TNFRSF10A divergent transcript (TNFRSF10A-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TNFRSF10A divergent transcript (TNFRSF10A-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call